Milvue vs ScreenPoint Transpara

Milvue reads conventional radiographs of the skeleton and chest, while ScreenPoint reads 2D and 3D mammograms. Different departments buy each.

Emergency radiology groups reading skeletal films are Milvue's customers. TechCare Trauma (K242171, decided January 17, 2025) detects fractures on radiographs, SmartChest (K232410, decided May 10, 2024) covers chest radiographs, and flagged exams move up the worklist. Partners on the RIS and PACS side include Dedalus and Evolucare, and the chest nodule and opacity findings are listed for Europe only.

Breast screening services are ScreenPoint's customers. The vendor says Transpara was the tool in the MASAI randomized trial and cites sensitivity of 80.5% against 73.8% at 98.5% specificity over 105,000 women from the Lancet paper by Lund University. The vendor also reports a 29% detection gain and a 44% workload cut, drawn from different analyses.